Australia's most trusted
source of pharma news
Wednesday, 19 November 2025
Posted 18 November 2023 PM
The Australian Novo Nordisk team has weathered the company's significant global restructure with "limited impact" although the exact number of job losses remains undisclosed.
Staff worldwide impacted by the downsize - 9000 roless globally - have been notified in most geographies, the company confirmed.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.